Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs.

Surface-functionalized mesoporous silica nanoparticles (MSNP) can be used as an efficient and safe carrier for bioactive molecules. In order to make the MSNP a more efficient delivery system, we modified the surface of the particles by a functional group that enhances cellular uptake and allows nucleic acid delivery in addition to traditional drug delivery. Noncovalent attachment of polyethyleneimine (PEI) polymers to the surface not only increases MSNP cellular uptake but also generates a cationic surface to which DNA and siRNA constructs could be attached. While efficient for intracellular delivery of these nucleic acids, the 25 kD PEI polymer unfortunately changes the safety profile of the MSNP that is otherwise very safe. By experimenting with several different polymer molecular weights, it was possible to retain high cellular uptake and transfection efficiency while reducing or even eliminating cationic MSNP cytotoxicity. The particles coated with the 10 kD PEI polymer were particularly efficient for transducing HEPA-1 cells with a siRNA construct that was capable of knocking down GFP expression. Similarly, transfection of a GFP plasmid induced effective expression of the fluorescent protein in >70% cells in the population. These outcomes were quantitatively assessed by confocal microscopy and flow cytometry. We also demonstrated that the enhanced cellular uptake of the nontoxic cationic MSNP enhances the delivery of the hydrophobic anticancer drug, paclitaxel, to pancreatic cancer cells. In summary, we demonstrate that, by a careful selection of PEI size, it is possible to construct cationic MSNP that are capable of nucleotide and enhanced drug delivery with minimal or no cytotoxicity. This novel use of a cationic MSNP extends its therapeutic use potential.

[1]  Mark E. Davis.  The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. , 2009, Molecular pharmaceutics.

[2]  R. Zhuo,et al.  Influence of disulfide density and molecular weight on disulfide cross-linked polyethylenimine as gene vectors. , 2009, Bioconjugate chemistry.

[3]  J. Dobson,et al.  Polyethyleneimine functionalized iron oxide nanoparticles as agents for DNA delivery and transfection , 2007 .

[4]  Taeghwan Hyeon,et al.  Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. , 2008, Angewandte Chemie.

[5]  Forrest M Kievit,et al.  A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells. , 2009, Biomaterials.

[6]  D. Fischer,et al.  Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives , 2005, The journal of gene medicine.

[7]  Small RNAs: Delivering the future , 2007, Nature.

[8]  Mark R Wiesner,et al.  Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. , 2006, Nano letters.

[9]  B. Nemery,et al.  In vitro cytotoxicity of textile paint components linked to the "Ardystil syndrome". , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  A. Mikos,et al.  Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Benjamin Gilbert,et al.  Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. , 2008, ACS nano.

[12]  A. Aigner,et al.  RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo , 2005, Gene Therapy.

[13]  Achim Goepferich,et al.  Layer-by-layer assembled gold nanoparticles for siRNA delivery. , 2009, Nano letters.

[14]  Weili Lin,et al.  Mesoporous silica nanospheres as highly efficient MRI contrast agents. , 2008, Journal of the American Chemical Society.

[15]  E. Stachowiak,et al.  Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Qiang Cai,et al.  Dilute solution routes to various controllable morphologies of MCM-41 silica with a basic medium , 2001 .

[17]  T. Schiestel,et al.  A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro. , 2000, Bioconjugate chemistry.

[18]  K. Heider,et al.  Polycation‐based DNA complexes for tumor‐targeted gene delivery in vivo , 1999, The journal of gene medicine.

[19]  A. Verkman,et al.  Chloride Concentration in Endosomes Measured Using a Ratioable Fluorescent Cl− Indicator , 2002, The Journal of Biological Chemistry.

[20]  J. Zink,et al.  Antimicrobial Activity of Silver Nanocrystals Encapsulated in Mesoporous Silica Nanoparticles , 2009 .

[21]  Rasmus Niemi,et al.  Targeting of porous hybrid silica nanoparticles to cancer cells. , 2009, ACS nano.

[22]  R. Langer,et al.  Intracellular delivery of core-shell fluorescent silica nanoparticles. , 2008, Biomaterials.

[23]  Victor S-Y Lin,et al.  A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. , 2004, Journal of the American Chemical Society.

[24]  Monty Liong,et al.  Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. , 2007, Small.

[25]  María Vallet-Regí,et al.  Mesoporous Materials for Drug Delivery , 2008 .

[26]  Jeffrey I. Zink,et al.  Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery , 2010, BiOS.

[27]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[28]  A. Lee,et al.  Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[29]  K. Finnie,et al.  Biodegradability of sol–gel silica microparticles for drug delivery , 2009 .

[30]  Shuming Nie,et al.  Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging. , 2008, Journal of the American Chemical Society.

[31]  V. S. Lin,et al.  Mesoporous silica nanoparticles deliver DNA and chemicals into plants. , 2007, Nature nanotechnology.

[32]  W. Xiong,et al.  Poly(l‐lysine)‐modified silica nanoparticles for the delivery of antisense oligonucleotides , 2004, Biotechnology and applied biochemistry.

[33]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Aigner,et al.  Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[35]  Adela C. Bonoiu,et al.  Nanotechnology approach for drug addiction therapy: Gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons , 2009, Proceedings of the National Academy of Sciences.

[36]  C. Barbé,et al.  Silica Particles: A Novel Drug‐Delivery System , 2004 .

[37]  Gerrit Borchard,et al.  Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures , 2002, AAPS PharmSci.

[38]  Shuming Nie,et al.  Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. , 2007, Journal of the American Chemical Society.

[39]  Karluss Thomas,et al.  Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[40]  Scott E. Martin,et al.  Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer. , 2006, Cancer research.

[41]  Cari D. Pentecost,et al.  Construction of a pH-driven supramolecular nanovalve. , 2006, Organic letters.

[42]  Monty Liong,et al.  Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. , 2008, ACS nano.

[43]  M. Demedts,et al.  Pulmonary toxicity of components of textile paint linked to the Ardystil syndrome: intratracheal administration in hamsters. , 1997, Occupational and Environmental Medicine.

[44]  Chung-Yuan Mou,et al.  Multifunctional Mesoporous Silica Nanoparticles for Intracellular Labeling and Animal Magnetic Resonance Imaging Studies , 2008, Chembiochem : a European journal of chemical biology.

[45]  B. Nemery,et al.  Polyanions protect against the in vitro pulmonary toxicity of polycationic paint components associated with the Ardystil syndrome. , 2001, Toxicology and applied pharmacology.

[46]  D. Moazed.  Small RNAs in transcriptional gene silencing and genome defence , 2009, Nature.

[47]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[48]  Young Jik Kwon,et al.  Controlled cytoplasmic and nuclear localization of plasmid DNA and siRNA by differentially tailored polyethylenimine. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[49]  Myung-Haing Cho,et al.  Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery. , 2008, International journal of pharmaceutics.

[50]  Juan L. Vivero-Escoto,et al.  Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. , 2009, Journal of the American Chemical Society.